Aragen Biologics launched CHOMax™, a new cell line development and early manufacturing platform that the company says supports an integrated path from DNA to IND-enabling clinical supply for suitable ...
In the current market environment, the challenge for manufacturers is to produce products with a short lifecycle and a high degree of customization within a short duration 1,2. With continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results